Additionally, it was demonstrated that miR-200b-3p directly targeted CXCL12/CXCR7 pathway, and the overexpression of CXCL12 reversed the inhibiting effects of miR-200b-3p on proliferation, migration, and invasion of NSCLC cells. The gene discussed is ACKR3; the disease is non-small cell lung carcinoma.